Delivery Order SPE2DB22D3102-SPE2DB24FK8TF
Award Date 10/26/23
Potential Completion Date 10/27/23
Potential Value $3.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply the Defense Logistics Agency (DLA) with 4566582548 units of the drug RESTASIS 0.05% eye emulsion. The contract is a delivery order with a firm fixed price of $1,325.95 and a completion date of December 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to supply RESTASIS 0.05% eye emulsion to the U.S. government. The Delivery Order contract, valued at $4,363.48, was awarded on May 30, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of May 31, 2024. This contract is not set-aside and is awarded under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at...
- This federal contract award to Amerisourcebergen Drug Corp, through the Defense Logistics Agency (DLA) Troop Support Medical, provides for the delivery of the pharmaceutical product RESTASIS 0.05% Eye Emulsion 30S. The contract has a ceiling value of $18,004.95 and an ultimate completion date of September 19, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RESTASIS 0.05% Eye Emulsion 30s. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,235.60 and a period of performance through January 27, 2025. The contract is not set aside for any specific business type. AmerisourceBergen is delivering this pharmaceutical product to support military treatment facilities,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,995.38 firm-fixed-price delivery order is for the supply of RESTASIS 0.05% eye emulsion, a specialty medication used to treat dry eye disease. This contract award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,124.25, is for the delivery of RESTASIS 0.05% eye emulsion 60s. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on July 22, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
- This federal contract award, valued at $11,648.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RESTASIS 0.05% eye emulsion, a specialty pharmaceutical product, with a completion date of October 21, 2024. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This federal contract award is for the supply of RESTASIS 0.05% EYE EMULSION 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,299.77 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of RESTASIS 0.05% eye emulsion. The award is a delivery order (SPE2DB23FL4M7) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,424.90, is a delivery order for the supply of RESTASIS 0.05% eye emulsion. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...